1-800-710-4674

Blogs

  • OHC is Evaluating a Promising New Treatment for Women with Triple Negative Breast Cancer

    OHC, Specialists in Cancer and Blood Disorders, Blogs 0 comments
    October 10, 2019

    OHC is evaluating a new treatment option for triple negative breast cancer through its clinical trials program. The results of the trial may provide new hope for women diagnosed with this aggressive form of breast cancer. Triple-negative breast cancer (TNBC) is a cancer that tests negative for estrogen receptors, progesterone receptors, and excess HER2 protein. […]

    Read More
  • New hope for lung cancer patients: OHC doctors report immunotherapy is changing a fatal cancer into a chronic condition

    OHC, Specialists in Cancer and Blood Disorders, Blogs 0 comments
    October 9, 2019

    lung cancer immunotherapy

    New research has just been published showing promising results for patients with non-small cell lung cancer (NSCLC) five years after treatment. Historically, NSCLC has been universally considered a fatal disease. Patients with stage 4 NSCLC who were treated with traditional chemotherapy had a 5-year survival rate of only 2%. Results from a recent study presented […]

    Read More
  • OHC is Evaluating a Promising New Treatment for Adult Acute Myeloid Leukemia

    OHC, Specialists in Cancer and Blood Disorders, Blogs 0 comments
    October 3, 2019

    leukemia clinical trial

    OHC is a leader in the development of a promising new treatment that is being studied in a new clinical trial for adult acute myeloid leukemia (AML). AML is the most common type of acute leukemia in adults and can progress quickly if not treated immediately. Standard treatment options include chemotherapy, radiation therapy, and blood […]

    Read More
  • OHC Clinical Trial Offers A New Option for Women With Advanced Ovarian Cancer

    OHC, Specialists in Cancer and Blood Disorders, Blogs 0 comments
    September 25, 2019

    ovarian cancer awareness month

    September is Ovarian Cancer Awareness Month. OHC is participating in a clinical trial that is evaluating rucaparib (a targeted drug) in combination with nivolumab (an immunotherapy drug) as a maintenance therapy in patients with newly diagnosed advanced ovarian cancer who haven’t had a response to a chemotherapy. Rucaparib is a type of targeted therapy drug […]

    Read More
  • OHC Offers an Enhanced Treatment Option to its Fight Against Prostate Cancer

    Evan Z. Lang, MD, MS, OHC medical oncologist and hematologist, Blogs 0 comments
    September 25, 2019

    enzalutamide doctor patient

    If you are a man, you’re probably somewhat concerned about prostate cancer since it’s the second most common cancer among men in the United States. If you are diagnosed with prostate cancer, our team of cancer experts at OHC can help you with a personalized treatment plan, and it may include a treatment option whose […]

    Read More
  • OHC Recommends Pink Ribbon Girls When Cancer Makes Daily Tasks Too Difficult

    OHC, Specialists in Cancer and Blood Disorders, Blogs 0 comments
    September 23, 2019

    pink ribbon girls meals

    A cancer diagnosis affects more than your health. It can affect every aspect of everything you do every day. The cancer experts at OHC are a strong resource for patients and families, providing leading-edge treatments, access to clinical trials, and supportive services like financial navigators, cancer genetic specialists, and other professionals. But sometimes even the […]

    Read More
  • Head & Neck Cancer Screenings

    OHC, Blogs, Events 0 comments
    September 18, 2019

    head and neck cancer screenings

    You’re invited to attend this FREE education and screening event hosted by OHC Mercy Health — West Hospital Mercy Health — Ear, Nose & Throat, West Thursday, October 24 5–7 P.M. Medical Office Building Mercy Health – West Hospital 3301 Mercy Health Blvd., Suite 500 Cincinnati, OH 45211 Registration is required. Call 513-751-2145 today to […]

    Read More